COVID-19
As the world grapples with the devastating consequences of climate change, Far Eastern New Century (FENC) is taking bold steps to reduce its carbon footprint and promote sustainable practices. The company's 9th edition of the Sustainable Report highlights its commitment to empowering possibilities and confronting challenges with corporate
COVID-19
The COVID-19 pandemic has placed significant strain on healthcare systems worldwide, with demand for services consistently outstripping available supply. According to research by the Johns Hopkins University School of Medicine, emergency departments are facing challenges in distinguishing patients who require hospital resources from those who can be safely discharged to
COVID-19
The global pediatric vaccines market has witnessed remarkable growth, driven by the development of safe and efficacious vaccines against life-threatening infectious diseases. The market, valued at USD 47.8 billion in 2021, is expected to reach USD 62 billion by 2027, fueled by increasing demand for pediatric vaccines and the
COVID-19
Senate Democrats are poised to propose $21 billion in new emergency funds to combat the coronavirus and prepare for emerging outbreaks, including the possibility of monkeypox. The proposal, championed by Sen. Patrick J. Leahy, sets aside $16 billion for the Department of Health and Human Services to fight the coronavirus
COVID-19
The US Food and Drug Administration (FDA) has revoked the Emergency Use Authorization (EUA) for Gilead Sciences' remdesivir, marketed as VEKLURY, for the treatment of coronavirus disease 2019 (COVID-19) in adults and pediatric patients. The revocation, effective April 25, 2022, was made possible by the approval of a supplemental
COVID-19
A recent study published in The Lancet has analyzed the effectiveness of the BNT162b2 (Pfizer-BioNTech) vaccine in children aged 5-11 years in Italy during the omicron variant (B.1.1.529) dominated epidemiological context. The research found that by April 13, 2022, only about 35.8% of the eligible children
COVID-19
The U.S. Equal Employment Opportunity Commission has issued updated guidance for employers on the interplay of workplace bias laws and COVID-19 workplace testing, vaccinations, and other return-to-work issues. The updated guidance, released July 12, 2022, addresses various aspects of COVID-19 and its impact on the workplace, including screening testing,
COVID-19
Marshfield Clinic Health System patients now have the opportunity to schedule appointments for pediatric Pfizer-BioNTech and Moderna COVID-19 vaccines, following the Centers for Disease Control and Prevention's recommendation for everyone 6 months and older to receive a COVID-19 vaccine. This development provides relief to parents and caregivers seeking
COVID-19
Lung cancer patients undergoing anticancer treatment who received the BNT162b2 mRNA vaccine exhibited a significant increase in antibody titers against the acute respiratory syndrome coronavirus-2 (SARS-CoV-2) spike protein S1 subunit receptor-binding domain. However, the immunogenicity in these patients was found to be inadequate compared to non-cancer patients. The study, published
COVID-19
Researchers from Emergency Clinical Hospital for Children in Bucharest, Romania, conducted a study to evaluate the reactogenicity and safety profile of the mRNA Pfizer-BioNTech COVID-19 vaccine among healthcare workers. The study involved an active survey conducted among the staff of a pediatric hospital in Bucharest, who were vaccinated with the
COVID-19
The High Potency APIs (HPAPIs) market is expected to grow at a significant rate, driven by factors such as increasing demand for oncology drugs, growing demand for antibody-drug conjugates, and advancements in HPAPI manufacturing technologies. The market is projected to reach USD 39.6 billion by 2027 from USD 24.
COVID-19
A new study on COVID-19, conducted by researchers at Clemson University, has introduced a significant breakthrough in diagnostic testing. The study focused on developing a multiplex RT-qPCR diagnostic assay for population surveillance of COVID-19 in closed populations, such as residential universities. The researchers utilized open-source liquid handling robots and thermocyclers
